| Trial ID: | L1250 |
| Source ID: | NCT00002047
|
| Associated Drug: |
Zidovudine
|
| Title: |
Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
HIV Infections|Kidney Failure, Chronic
|
| Interventions: |
DRUG: Zidovudine
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Glaxo Wellcome
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2005-06-24
|
| Locations: |
Univ of Maryland at Baltimore, Baltimore, Maryland, 21201, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00002047
|
